Clinical Trial

WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Endoscopic ultrasound (EUS)-guided transluminal drainage has become a first-line treatment modality for symptomatic pancreatic pseudocysts. Despite the increasing popularity of lumen-apposing metal stents (LAMSs), the use of a LAMS is limited by its high costs and specific adverse events compared to plastic stent placement. To date, there has been a paucity of data on the appropriate stent type in this setting. This trial aims to assess the non-inferiority of plastic stents to a LAMS for the initial EUS-guided drainage of pseudocysts.
Trial Details
NCT Number NCT06133023
Lead Sponsor Tokyo University
Conditions Pancreatic Fluid Collection, Pancreatitis, Pancreatic Pseudocyst
Enrollment 80 participants
Start Date 2023-11
Primary Completion 2026-10 (estimated)
Study Completion 2033-09 (estimated)
Updated on ClinicalTrials.gov 2023-11-15